Global Genomic Biomarkers In-Depth Monitoring and Development Analysis Report 2023

Report ID: ARS11293 | Category: Healthcare | Pages: 118 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3850.00 Multi User-$6200.00

Report Description
View Table of Contents

Report Summary

The global Genomic Biomarkers market size in 2022 is 7590.0 million US dollars, and it is expected to be 23469.7 million US dollars by 2029, with a compound annual growth rate of 17.50% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Genomic Biomarkers market include Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Myriad Genetics, Inc (U.S.), Eurofins Scientific (Luxembourg), and QIAGEN (Germany). The share of the top 3 players in the Genomic Biomarkers market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Genomic Biomarkers market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Oncology accounted for XX% of Genomic Biomarkers market in 2022. Cardiovascular Diseases share of XX%.
Diagnostic accounted for XX% of the Genomic Biomarkers market in 2022. Research Laboratories accounts for XX%.

This Genomic Biomarkers market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

Genomic Biomarkers market country level analysis
The countries covered in the Genomic Biomarkers market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and Genomic Biomarkers Market Share Analysis
Genomic Biomarkers market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Genomic Biomarkers market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapters 2-7: Provide Global, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Genomic Biomarkers market type, application, player and country market segmentation data.
Chapters 8-9: Segmented the global Genomic Biomarkers market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 10: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the Genomic Biomarkers industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapter 12: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
South America
Brazil
Argentina
Colombia
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
Thermo Fisher Scientific (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
Myriad Genetics, Inc (U.S.)
Eurofins Scientific (Luxembourg)
QIAGEN (Germany)
Bio-Rad Laboratories, Inc. (U.S.)
MedGenome (India)
Almac Group (U.K.)
Sema4 (U.S.)
GENOME LIFE SCIENCES (India)
Creative Diagnostics (U.S.)
FOUNDATION MEDICINE, INC. (U.S.)
Quanterix (U.S.)

Types list
Oncology
Cardiovascular Diseases
Neurological Diseases
Renal Disorders
Others

Application list
Diagnostic
Research Laboratories
Hospitals
Others

Table of Content

1 Genomic Biomarkers Market Introduction and Overview
1.1 Genomic Biomarkers Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Global Market Growth Trends Analysis
2.1 Global Genomic Biomarkers Market Size & Forecast (2018-2029)
2.2 Genomic Biomarkers Growth Trends Analysis by Regions
2.2.1 Genomic Biomarkers Market Size by Regions: 2018 VS 2023 VS 2029
2.2.2 Genomic Biomarkers Historic Market Size by Regions (2018-2023)
2.2.3 Genomic Biomarkers Forecasted Market Size by Regions (2023-2029)
2.2.4 North America Genomic Biomarkers Market Size & Forecast (2018-2029)
2.2.5 Europe Genomic Biomarkers Market Size & Forecast (2018-2029)
2.2.6 Asia-Pacific Genomic Biomarkers Market Size & Forecast (2018-2029)
2.2.7 Latin America Genomic Biomarkers Market Size & Forecast (2018-2029)
2.2.8 Middle East & Africa Genomic Biomarkers Market Size & Forecast (2018-2029)
3 North America
3.1 North America Genomic Biomarkers Revenue by Countries
3.1.1 North America Genomic Biomarkers Revenue by Countries (2018-2029)
3.2 North America Genomic Biomarkers Revenue by Players
3.3 North America Genomic Biomarkers Revenue by Types
3.4 North America Genomic Biomarkers Revenue by Applications
3.5 United States
3.6 Canada
4 Asia Pacific
4.1 Asia Pacific Genomic Biomarkers Revenue by Countries
4.1.1 Asia Pacific Genomic Biomarkers Revenue by Countries (2018-2029)
4.2 Asia Pacific Genomic Biomarkers Revenue by Players
4.3 Asia Pacific Genomic Biomarkers Revenue by Types
4.4 Asia Pacific Genomic Biomarkers Revenue by Applications
4.5 China
4.6 Japan
4.7 Korea
4.8 Southeast Asia
4.9 India
4.10 Australia
5 Europe
5.1 Europe Genomic Biomarkers Revenue by Countries
5.1.1 Europe Genomic Biomarkers Revenue by Countries (2018-2029)
5.2 Europe Genomic Biomarkers Revenue by Players
5.3 Europe Genomic Biomarkers Revenue by Types
5.4 Europe Genomic Biomarkers Revenue by Applications
5.5 Germany
5.6 France
5.7 UK
5.8 Italy
5.9 Russia
5.10 Spain
5.11 Nordic
6 Latin America
6.1 Latin America Genomic Biomarkers Revenue by Countries
6.1.1 Latin America Genomic Biomarkers Revenue by Countries (2018-2029)
6.2 Latin America Genomic Biomarkers Revenue by Players
6.3 Latin America Genomic Biomarkers Revenue by Types
6.4 Latin America Genomic Biomarkers Revenue by Applications
6.5 Brazil
6.6 Argentina
6.7 Colombia
6.8 Mexico
7 Middle East & Africa
7.1 Middle East & Africa Genomic Biomarkers Revenue by Countries
7.1.1 Middle East & Africa Genomic Biomarkers Revenue by Countries (2018-2029)
7.2 Middle East & Africa Genomic Biomarkers Revenue by Players
7.3 Middle East & Africa Genomic Biomarkers Revenue by Types
7.4 Middle East & Africa Genomic Biomarkers Revenue by Applications
7.5 Egypt
7.6 South Africa
7.7 Israel
7.8 Turkey
7.9 GCC Countries
8 Global Genomic Biomarkers Historical and Forecast Market Analysis by Type
8.1 Global Genomic Biomarkers Revenue and Market Share by Type
8.2 Global Genomic Biomarkers Market Forecast by Type (2023-2029)
9 Global Genomic Biomarkers Historical and Forecast Market Analysis by Application
9.1 Global Genomic Biomarkers Revenue Market Share by Application (2018-2023)
9.2 Genomic Biomarkers Market Forecast by Application (2023-2029)
10 Genomic Biomarkers Industry Dynamic Analysis
10.1 Genomic Biomarkers Market Trends Analysis
10.2 Genomic Biomarkers Market Drivers Analysis
10.3 Genomic Biomarkers Market Challenges Analysis
10.4 Genomic Biomarkers Market Restraints Analysis
10.5 Genomic Biomarkers Industry Mergers & Acquisitions
10.6 Genomic Biomarkers Industry New Entrants and Expansion Plans
11 Players Profiles
11.1  Thermo Fisher Scientific (U.S.)
11.1.1 Thermo Fisher Scientific (U.S.) Company Profile
11.1.2 Genomic Biomarkers Product Overview
11.1.3 Thermo Fisher Scientific (U.S.) Genomic Biomarkers Market Performance (2018-2023)
11.1.4 Thermo Fisher Scientific (U.S.) Business Overview
11.2  F. Hoffmann-La Roche Ltd (Switzerland)
11.2.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
11.2.2 Genomic Biomarkers Product Overview
11.2.3 F. Hoffmann-La Roche Ltd (Switzerland) Genomic Biomarkers Market Performance (2018-2023)
11.2.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
11.3  Myriad Genetics, Inc (U.S.)
11.3.1 Myriad Genetics, Inc (U.S.) Company Profile
11.3.2 Genomic Biomarkers Product Overview
11.3.3 Myriad Genetics, Inc (U.S.) Genomic Biomarkers Market Performance (2018-2023)
11.3.4 Myriad Genetics, Inc (U.S.) Business Overview
11.4  Eurofins Scientific (Luxembourg)
11.4.1 Eurofins Scientific (Luxembourg) Company Profile
11.4.2 Genomic Biomarkers Product Overview
11.4.3 Eurofins Scientific (Luxembourg) Genomic Biomarkers Market Performance (2018-2023)
11.4.4 Eurofins Scientific (Luxembourg) Business Overview
11.5  QIAGEN (Germany)
11.5.1 QIAGEN (Germany) Company Profile
11.5.2 Genomic Biomarkers Product Overview
11.5.3 QIAGEN (Germany) Genomic Biomarkers Market Performance (2018-2023)
11.5.4 QIAGEN (Germany) Business Overview
11.6  Bio-Rad Laboratories, Inc. (U.S.)
11.6.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile
11.6.2 Genomic Biomarkers Product Overview
11.6.3 Bio-Rad Laboratories, Inc. (U.S.) Genomic Biomarkers Market Performance (2018-2023)
11.6.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
11.7  MedGenome (India)
11.7.1 MedGenome (India) Company Profile
11.7.2 Genomic Biomarkers Product Overview
11.7.3 MedGenome (India) Genomic Biomarkers Market Performance (2018-2023)
11.7.4 MedGenome (India) Business Overview
11.8  Almac Group (U.K.)
11.8.1 Almac Group (U.K.) Company Profile
11.8.2 Genomic Biomarkers Product Overview
11.8.3 Almac Group (U.K.) Genomic Biomarkers Market Performance (2018-2023)
11.8.4 Almac Group (U.K.) Business Overview
11.9  Sema4 (U.S.)
11.9.1 Sema4 (U.S.) Company Profile
11.9.2 Genomic Biomarkers Product Overview
11.9.3 Sema4 (U.S.) Genomic Biomarkers Market Performance (2018-2023)
11.9.4 Sema4 (U.S.) Business Overview
11.10  GENOME LIFE SCIENCES (India)
11.10.1 GENOME LIFE SCIENCES (India) Company Profile
11.10.2 Genomic Biomarkers Product Overview
11.10.3 GENOME LIFE SCIENCES (India) Genomic Biomarkers Market Performance (2018-2023)
11.10.4 GENOME LIFE SCIENCES (India) Business Overview
11.11  Creative Diagnostics (U.S.)
11.11.1 Creative Diagnostics (U.S.) Company Profile
11.11.2 Genomic Biomarkers Product Overview
11.11.3 Creative Diagnostics (U.S.) Genomic Biomarkers Market Performance (2018-2023)
11.11.4 Creative Diagnostics (U.S.) Business Overview
11.12  FOUNDATION MEDICINE, INC. (U.S.)
11.12.1 FOUNDATION MEDICINE, INC. (U.S.) Company Profile
11.12.2 Genomic Biomarkers Product Overview
11.12.3 FOUNDATION MEDICINE, INC. (U.S.) Genomic Biomarkers Market Performance (2018-2023)
11.12.4 FOUNDATION MEDICINE, INC. (U.S.) Business Overview
11.13  Quanterix (U.S.)
11.13.1 Quanterix (U.S.) Company Profile
11.13.2 Genomic Biomarkers Product Overview
11.13.3 Quanterix (U.S.) Genomic Biomarkers Market Performance (2018-2023)
11.13.4 Quanterix (U.S.) Business Overview
12 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Genomic Biomarkers In-Depth Monitoring and Development Analysis Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?